Report Highlights


Each report includes carefully vetted recommendations for consideration, provided in the context of a primary cancer type.

Therapeutic Implications

Imagia Canexia Health’s therapeutic recommendations are based on gene mutations and the clinical data provided.

Clinical Trials

Clinical trials included have been reviewed and selected by certified clinical molecular geneticists.

Stay Connected

Don’t miss out on news, webinars, and other resources from Imagia Canexia Health. Subscribe to our mailing list to stay up to date on the latest. You can opt-out at any time.

Our Solutions

Plasma Follow It®

Imagia Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.

Learn About Follow It


Imagia Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.

Learn About Tissue Assays

Interested in seeing a demo?

Contact us to schedule time with one of our PhD-level Customer Success team members.

Contact Us